| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
155 |
| issn |
0901-9928 |
| issueIdentifier |
4 |
| pageRange |
153-155 |
| publicationName |
Pharmacology & Toxicology |
| startingPage |
153 |
| bibliographicCitation |
Morgan G. Should aspirin be used to counteract 'salicylate deficiency'? Pharmacol Toxicol. 2003 Oct;93(4):153–5. doi: 10.1034/j.1600-0773.2003.930401.x. PMID: 14629738. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8294eec7e966601017953deef57f321f |
| date |
200310 |
| identifier |
https://doi.org/10.1034/j.1600-0773.2003.930401.x
https://pubmed.ncbi.nlm.nih.gov/14629738 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6574
https://portal.issn.org/resource/ISSN/0901-9928 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Should Aspirin be Used to Counteract ‘Salicylate Deficiency’? |
| discusses |
http://id.nlm.nih.gov/mesh/M0019362
http://id.nlm.nih.gov/mesh/M0001864 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D012459Q000378
http://id.nlm.nih.gov/mesh/D001241Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D009369Q000517
http://id.nlm.nih.gov/mesh/D012459Q000737
http://id.nlm.nih.gov/mesh/D002908
http://id.nlm.nih.gov/mesh/D005638Q000737
http://id.nlm.nih.gov/mesh/D002318Q000517
http://id.nlm.nih.gov/mesh/D000544Q000517
http://id.nlm.nih.gov/mesh/D011634
http://id.nlm.nih.gov/mesh/D014675Q000737
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675850
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 |